Pfizer (PFE):

Average: 2008 2007 2006

Revenues ($mil): $48,296.00 $48,418.00 $48,371.00

-2.04% -0.25% 0.10% -5.71%
Core Operating Costs: $30,594.00 $34,954.00 $30,828.00
-3.46% -12.47% 13.38% -16.05%
Net Income: $8,104.00 $8,144.00 $19,337.00

ROE: 16.1% 12.0% 12.5% 27.1%

Gross Margin: 32.03% 36.65% 27.81% 36.27%
Profit Margin: 22.19% 16.78% 16.82% 39.98%

SGAE as % of net sales: 32.46% 30.10% 32.27% 32.23%

Annual Change (%): -1.60% -6.73% 0.14% -2.73%

R&D ($mil): $7,945.00 $8,089.00 $7,599.00

R&D as % of net sales: 15.60% 16.45% 16.71% 15.71%
Annual Change (%): 0.91% -1.78% 6.45% 2.11%

EPS: 1.20 2.20 2.06

Dividends: 1.28 1.16 0.96
Annual Change (%): 19.6% 10.3% 20.8% 26.3%
Payout: 55.1% 106.7% 52.7% 46.6%
Yield: 4.36% 7.23% 5.09% 3.71%

LT Debt/Equity: 0.10 0.11 0.11 0.08

BVPS: $9.95 $9.60 $9.98
Annual Change (%): 2.5% 3.6% -3.8% 12.4%
Current Ratio: 2.15 2.16
Year End Price: $17.71 $22.77 $25.90
Price-to-Earnings: 12.38 14.76 10.35 12.57
Price-to-Book: 1.78 2.37 2.60

Sales by Business Segment:

Pharmaceutical: 91.5% 91.8% 93.2%
Animal Health: 5.8% 5.4% 4.8%
Corporate: 2.7% 2.8% 2.0%
 2005 2004

$51,298.00 $52,516.00
-2.32%
$36,720.00 $36,245.00
1.31%
$8,085.00 $11,361.00

12.3% 16.6%
28.42% 30.98%
15.76% 21.63%

33.13% 32.19%
2.94%

$7,442.00 $7,684.00
14.51% 14.63%
-3.15%

2.02 2.12
0.76 0.68
11.8%
37.6% 32.1%
3.26% 2.53%

0.10 0.11
$8.88 $9.10
-2.4%
1.47 1.48
$23.32 $26.89
11.54 12.68
2.63 2.95

93.4%
4.6%
2.0%